Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYTARABINE\DAUNORUBICIN Cause Rash? 109 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 109 reports of Rash have been filed in association with CYTARABINE\DAUNORUBICIN. This represents 5.4% of all adverse event reports for CYTARABINE\DAUNORUBICIN.

109
Reports of Rash with CYTARABINE\DAUNORUBICIN
5.4%
of all CYTARABINE\DAUNORUBICIN reports
6
Deaths
38
Hospitalizations

How Dangerous Is Rash From CYTARABINE\DAUNORUBICIN?

Of the 109 reports, 6 (5.5%) resulted in death, 38 (34.9%) required hospitalization, and 6 (5.5%) were considered life-threatening.

Is Rash Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYTARABINE\DAUNORUBICIN. However, 109 reports have been filed with the FAERS database.

What Other Side Effects Does CYTARABINE\DAUNORUBICIN Cause?

Febrile neutropenia (394) Acute myeloid leukaemia (175) Pyrexia (157) Death (147) Sepsis (126) Off label use (119) Pneumonia (118) Acute myeloid leukaemia recurrent (83) Disease progression (79) Therapeutic product effect incomplete (77)

What Other Drugs Cause Rash?

DUPILUMAB (30,895) ADALIMUMAB (18,690) LENALIDOMIDE (15,794) ADAPALENE (15,709) METHOTREXATE (15,519) ETANERCEPT (15,381) AVOBENZONE\OCTISALATE\OCTOCRYLENE (12,630) TOCILIZUMAB (12,327) ABATACEPT (12,168) RITUXIMAB (12,102)

Which CYTARABINE\DAUNORUBICIN Alternatives Have Lower Rash Risk?

CYTARABINE\DAUNORUBICIN vs DABIGATRAN CYTARABINE\DAUNORUBICIN vs DABIGATRAN ETEXILATE CYTARABINE\DAUNORUBICIN vs DABRAFENIB CYTARABINE\DAUNORUBICIN vs DABRAFENIB\TRAMETINIB CYTARABINE\DAUNORUBICIN vs DACARBAZINE

Related Pages

CYTARABINE\DAUNORUBICIN Full Profile All Rash Reports All Drugs Causing Rash CYTARABINE\DAUNORUBICIN Demographics